🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Got Hemophilia B? If you take Coagulation Factor IX (Recombinant) GlycoPEGylated (Rebinyn®) you could join a research study looking at long-term safety and effectiveness. Interested? Find out more: gothemophiliab.com/hemophiliab.ht…

The Coalition for Hemophilia B proudly offers the Gene Therapy Support Network, designed to empower and support patients dealing with Hemophilia B who are considering or undergoing gene therapy. Learn more and register: ​​hemob.org/upcoming-events #hemob #hemophilia #genetherapy

Updated guidelines on management of pediatric venous thrombosis are now published by the ASH and ISTH Important updates on upfront use of DOACs, and duration of anticoagulation in children with thrombosis!!! American Society of Pediatric Hematology/Oncology Hemostasis and Thrombosis Research Society THSNA

Help us learn more about Hemophilia B! New research study open studying the safety and effectiveness of Rebinyn® (Coagulation Factor IX (Recombinant) GlycoPEGylated). Learn how to join today! gothemophiliab.com/hemophiliab.ht…

The 5-year follow-up of the 3 participants in the Phase 2b study, showed etranacogene dezaparvovec maintained near-normal FIX levels and eliminated the need for prophylaxis, with no late-emergent safety issues. 💉Read more: bit.ly/43VHxM9

Thank you Hemab for this important information. If you are interested, ATHN (American Thrombosis and Hemostasis Network) invites you to join the Glanzmann Thrombasthenia (GT) research study. gotglanzmann.com/user_managemen…

ATHN Data Summit 2025 is coming in October. Make sure you're a part of this premier virtual event, register today! athn.org/events/data-su…

Join ATHN at the ISTH 2025 Congress! ATHN is proud of our many presenters who will be sharing their research updates and insights at the ISTH 2025 Congress in Washington, D.C., June 21-25. Two oral presentations and nine poster presentations!

Make sure you catch the action at #ISTH2025 Tami Singleton Takeda

Make sure you're a part of the action at #ISTH2025 Tami Singleton HEMA Biologics

Why are women still underrepresented in health care leadership? Gendered ageism—a mix of sexism and ageism—plays a big role, disproportionately impacting women as they age. Women's representation in leadership is essential to advance #WomensHealth. Read more from STAT:

Join ATHN at the ISTH 2025 Congress! ATHN is proud of our many presenters who will be sharing their research updates and insights at the #ISTH2025 Congress in Washington, D.C., June 21-25. Two oral presentations and nine poster presentations!

A 44-year-old man has become the first person to receive gene therapy for haemophilia B on the NHS. haemophilia.org.uk/first-nhs-pati…

Our superstars Dr. Kate Pratt and Dr. Niki Machin rockin #ISTH2025 with their poster on the Transcends INHIBIT module. athn.org/what-we-do/nat… Tami Singleton